Endobronchial Ultrasound Biopsy Market Size
| Study Period | 2018 - 2028 |
| Base Year For Estimation | 2021 |
| Forecast Data Period | 2024 - 2028 |
| CAGR | 4.36 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Endobronchial Ultrasound Biopsy Market Analysis
Endobronchial ultrasound (EBUS) is a technique that is used by pulmonologists to sample (biopsy) and visualize the structure around the tracheobronchial tree. The EBUS and endobronchial ultrasound-guided transbronchial needle aspiration (EBUS TBNA) are techniques that are effective procedures to evaluate pulmonary nodules and diagnose lung infections and stages of lung cancer.
The endobronchial ultrasound biopsy market is estimated to grow in the near future. The rise in the geriatric population with increasing incidence of diseases that require endoscopic ultrasound procedures, large patient pool with respiratory disorders, and an increase in demand for minimally invasive procedures are the primary drivers that propel the growth of this market. However, the cost of medical devices and the lack of reimbursement policies in developing countries are likely to restrain the market.
Endobronchial Ultrasound Biopsy Market Trends
This section covers the major market trends shaping the Endobronchial Ultrasound Biopsy Market according to our research experts:
Cancer Diagnosis segment is expected to dominate the market
Cancer Research UK suggests that the population suffering from cancer is expected to increase in the future. If the incidence of major cancers and population growth continue to be consistent, there may be 27.5 million new cancer cases worldwide each year, by 2040. This is an increase of 61.7% from 2018 and it is expected to be higher in males, with an increase of about 67.6%, as compared to females, with an estimated increase of 55.3%. Moreover, lung cancer is the 3rd most common cancer in the UK, accounting for 13% of all new cancer cases, and is also expected to increase. As a result of high and increasing prevalence of Cancer, the demand for Endobronchial Ultrasound Biopsy procedures is expected to increase in the future
North America is expected to dominate the market
According to the American Cancer Society’s 2019 report, an estimated 228,150 new cases of lung cancer comprising of 116,440 men and 111,710 women were estimated to have occurred in the United States (US) in 2019. Moreover, about 142,670 deaths from lung cancer (76,650 in men and 66,020 in women) were also estimated.
However, the US has a well-structured healthcare system that promotes researches and technological advancements. As a result, most global players have their presence in the US. Hence the demand for Endobronchial Ultrasound Biopsy procedures for cancer diagnosis helps the market grow.
Endobronchial Ultrasound Biopsy Industry Overview
The majority of the Endobronchial Ultrasound Biopsy equipment is being manufactured by the global key players. Market leaders with more funds for research and a better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing the emergence of some small players due to the rise of awareness. This has also helped the market grow.
Endobronchial Ultrasound Biopsy Market Leaders
Medtronic PLC
Boston Scientific Corporation
Cook Group Incorporated
CONMED Corporation
Olympus Corporation
*Disclaimer: Major Players sorted in no particular order
Endobronchial Ultrasound Biopsy Market Report - Table of Contents
-
1. INTRODUCTION
-
1.1 Study Deliverables
-
1.2 Study Assumptions
-
1.3 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Rising Geriatric Population
-
4.2.2 Increasing Prevalence of Respiratory Disorders
-
4.2.3 Increasing demand for Minimally Invasive Procedures
-
-
4.3 Market Restraints
-
4.3.1 High Cost of Equipment
-
4.3.2 Lack Reimbursement Policies in Developing Countries
-
-
4.4 Porter's Five Force Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Product
-
5.1.1 Biopsy Forceps
-
5.1.2 Cytology Brushes
-
5.1.3 Biopsy Needles
-
5.1.4 Transbronchial Aspiration Needles
-
5.1.5 Spray Catheters
-
5.1.6 Others
-
-
5.2 By Application
-
5.2.1 Cancer Diagnosis
-
5.2.2 Infection Diagnosis
-
5.2.3 Others
-
-
5.3 Geography
-
5.3.1 North America
-
5.3.1.1 United States
-
5.3.1.2 Canada
-
5.3.1.3 Mexico
-
-
5.3.2 Europe
-
5.3.2.1 Germany
-
5.3.2.2 United Kingdom
-
5.3.2.3 France
-
5.3.2.4 Italy
-
5.3.2.5 Spain
-
5.3.2.6 Rest of Europe
-
-
5.3.3 Asia-Pacific
-
5.3.3.1 China
-
5.3.3.2 Japan
-
5.3.3.3 India
-
5.3.3.4 Australia
-
5.3.3.5 South Korea
-
5.3.3.6 Rest of Asia-Pacific
-
-
5.3.4 Middle-East and Africa
-
5.3.4.1 GCC
-
5.3.4.2 South Africa
-
5.3.4.3 Rest of Middle-East and Africa
-
-
5.3.5 South America
-
5.3.5.1 Brazil
-
5.3.5.2 Argentina
-
5.3.5.3 Rest of South America
-
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 ACE Medical Devices Pvt. Ltd.
-
6.1.2 Boston Scientific Corporation
-
6.1.3 CLINODEVICE
-
6.1.4 CONMED Corporation
-
6.1.5 Cook Group Incorporated
-
6.1.6 ENDO-FLEX GmbH
-
6.1.7 Medi-Globe Corporation
-
6.1.8 Medtronic Plc
-
6.1.9 Micro-Tech Endoscopy
-
6.1.10 Olympus Corporation
-
- *List Not Exhaustive
-
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Endobronchial Ultrasound Biopsy Industry Segmentation
Endobronchial ultrasound is a technique that is used for biopsy and visualization of the structure around the tracheobronchial tree.
| By Product | |
| Biopsy Forceps | |
| Cytology Brushes | |
| Biopsy Needles | |
| Transbronchial Aspiration Needles | |
| Spray Catheters | |
| Others |
| By Application | |
| Cancer Diagnosis | |
| Infection Diagnosis | |
| Others |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Endobronchial Ultrasound Biopsy Market Research FAQs
What is the current Endobronchial Ultrasound Biopsy Market size?
The Endobronchial Ultrasound Biopsy Market is projected to register a CAGR of 4.36% during the forecast period (2023-2028).
Who are the key players in Endobronchial Ultrasound Biopsy Market?
Medtronic PLC, Boston Scientific Corporation, Cook Group Incorporated, CONMED Corporation and Olympus Corporation are the major companies operating in the Endobronchial Ultrasound Biopsy Market.
Which is the fastest growing region in Endobronchial Ultrasound Biopsy Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2023-2028).
Which region has the biggest share in Endobronchial Ultrasound Biopsy Market?
In 2023, the North America accounts for the largest market share in the Endobronchial Ultrasound Biopsy Market.
Endobronchial Ultrasound Biopsy Industry Report
Statistics for the 2023 Endobronchial Ultrasound Biopsy market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Endobronchial Ultrasound Biopsy analysis includes a market forecast outlook to 2028 and historical overview. Get a sample of this industry analysis as a free report PDF download.
